松瑞
松瑞藥 Stock: price and insider trades · Taiwan
松瑞藥: what insiders have been doing
Insider filings for 松瑞藥 are scarce in the TWSE / TPEx (MOPS) feed, the latest one published on 16 December 2016. This page will fill in as new trades are disclosed. This summary is built from TWSE / TPEx (MOPS) disclosures alone and does not predict where the share price will go.
Insider Decl.
9
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 5,452 of 26,911 companies
66.8
score / 100
Value52
Quality82
FCF yld-2.4%
Earn yld7.8%
EV/EBITDA11.2x
ROE26%
Gross mgn35%
Net mgn45%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NT$21
Analyst consensus
Income statement
RevenueNT$1.2B
Gross profitNT$423.4M35% margin
EBITDANT$631.6M53% margin
Net incomeNT$537.4M91.9% margin
Valuation
PER (trailing)7.5x
P/Book1.6x
Beta0.11
Balance sheet & cash
Market capNT$6.9B
Total debtNT$183.2M
Free Cash Flow-NT$164.3M
Debt / Equity7%
Profitability & ownership
ROE25.7%
ROA1.5%
% insiders21.7%
% institutions4.3%
Last declaration on 16 December 2016
Declarations9 total
- 995,000 sharesShareTPExTWMOPS:4167:105/12/16:啟航創業投資股份有限公司:0cepc51
- 20,000 sharesShareTPExTWMOPS:4167:105/11/23:潘世賢:0jxkb16
- 20,000 sharesShareTPExTWMOPS:4167:105/11/23:田秀英:16lrpbt
- 30,000 sharesShareTPExTWMOPS:4167:105/11/23:林明發:0qk29wp
- 109,000 sharesShareTPExTWMOPS:4167:105/06/20:顧曼芹:167zysz
- 20,000 sharesShareTPExTWMOPS:4167:105/06/20:潘世賢:0m0viaj
- 40,000 sharesShareTPExTWMOPS:4167:104/12/22:游宏樞:1rs6usw
- 128,000 sharesShareTPExTWMOPS:4167:104/12/22:顧曼芹:035feb7
- 40,000 sharesShareTPExTWMOPS:4167:104/06/29:游宏樞:1u7y94q
9 of 9 declarations
About 松瑞藥
松瑞藥 is a company listed on the XTAI market, specializing in the pharmaceutical sector. It focuses on the development and commercialization of innovative medications.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
